Use Of A Lactic Acid Plus Lactoserum Intimate Liquid Soap For External Hygiene In The Prevention Of Bacterial Vaginosis Recurrence After Metronidazole Oral Treatment [uso Do ácido Láctico Com Lactoserum Em Sabonete Líquido íntimo Para Higiene Externa Na Prevenção Da Recorrência De Vaginose Bacteriana Após Tratamento Oral Com Metronidazol]

dc.creatorValeria Bahamondes M.
dc.creatorPortugal P.M.
dc.creatorBrolazo E.M.
dc.creatorSimoes J.A.
dc.creatorBahamondes L.
dc.date2011
dc.date2015-06-30T20:36:59Z
dc.date2015-11-26T14:52:03Z
dc.date2015-06-30T20:36:59Z
dc.date2015-11-26T14:52:03Z
dc.date.accessioned2018-03-28T22:04:01Z
dc.date.available2018-03-28T22:04:01Z
dc.identifier
dc.identifierRevista Da Associacao Medica Brasileira. , v. 57, n. 4, p. 415 - 420, 2011.
dc.identifier1044230
dc.identifier10.1590/S0104-42302011000400015
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-80052208004&partnerID=40&md5=d842437c1df228e22933ff514a4a8ac3
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/108637
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/108637
dc.identifier2-s2.0-80052208004
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1254712
dc.descriptionObjective: To determine the recurrence of bacterial vaginosis (BV) after the use of a lactic acid plus lactoserum liquid soap starting immediately after the treatment with oral metronidazole and the quality of life of the participants. Methods: A total of 123 women with diagnosis of BV with at least three of the following criteria: 1) homogeneous vaginal discharge without inflammation of the vagina or vulva; 2) vaginal pH > 4.5; 3) positive Whiff test; and 4) clue cells in more than 20% of the epithelial cells in the vagina. A Nugent score > 4 in the vaginal bacterioscopy was also used. After BV diagnosis, metronidazole 500 mg was administered orally bid during 7 days. Patients cured of BV were then instructed to use 7.5 to 10 mL of a lactic acid plus lactoserum liquid soap once-a-day for hygiene of the external genital region. Three subsequent control visits after starting the hygiene treatment (30, 60, and 90 days; ± 5 days) were scheduled. A questionnaire was applied in the form of visual analogue scale (VAS) in all the visits regarding: 1) level of comfort at the genital region; 2) malodorous external genitalia; 3) comfort in sexual intercourse; 4) satisfaction with intimate hygiene; and 5) self-esteem. Results: Ninety two (74.8%) women initiated the use of a lactic acid plus lactoserum liquid soap at visit 1. At visit 2, 3, and 4 there were 84, 62 and 42 women available for evaluation, respectively. The rate of recurrence of BV was 19.0%, 24.2% and 7.1%, respectively in the three visits and vaginal candidiasis was observed in five treated women. Quality of life was evaluated in the 42 women who completed the four visits schedule and there were significant improvement in the five domains assessed. Conclusion: A lactic acid plus lactoserum liquid soap for external intimate hygiene may be an option for the prevention of BV recurrence after treatment and cure with oral metronidazole. © 2011 Elsevier Editora Ltda.
dc.description57
dc.description4
dc.description415
dc.description420
dc.descriptionHillier, S., Holmes, K.K., Bacterial vaginosis (1999) Sexually Transmitted Diseases, pp. 563-586. , In: Holmes KK, Mardh PA, Sparling PF, Lemon SM, Stamm WE, Piot P et al., editors, 3 rd ed. New York: McGraw-Hill
dc.descriptionSpiegel, C.A., Gardnerella vaginalis and Mobiluncus Species (2000) Principles and Practice of Infectious Diseases, 2, pp. 2383-2386. , In: Mandell GL, Bennett JE, Dolin R, editors, 5 th Philadelphia: Churchill Livingstone
dc.descriptionMartin, H.L., Richardson, B.A., Nyange, P.M., Lavreys, L., Hiller, S.L., Chohan, B., Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition (1999) J Infect Dis, 180, pp. 1863-1868
dc.descriptionGuidelines for treatment of sexually transmitted diseases (1998) MMWR Morb Mortal Wkly Rep, 47 (RR-1), pp. 70-79. , Centers for Disease Control and Prevention, 1998
dc.descriptionLivengood, C.H., Soper, D.E., Sheehan, K.L., Fenner, D.E., Martens, M.G., Nelson, A.L., Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis (1999) Sex Transm Dis, 26, pp. 137-142
dc.descriptionSobel, J.D., Schmitt, C., Meriwether, C., Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin (1993) J Infect Dis, 167, pp. 783-784
dc.descriptionBoris, J., Pahlson, C., Larsson, P.G., Six years observation after successful treatment of bacterial vaginosis (1997) Infect Dis Obstet Gynecol, 5, pp. 297-302
dc.descriptionFerris, D.G., Francis, S.L., Dickman, E.D., Miler-Miles, K., Waller, J.L., McClendon, N., Variability of vaginal pH determination by patients and clinicians (2006) J Am Board Fam Med, 19, pp. 368-373
dc.descriptionSoper, D.E., Gynecologic complications of bacterial vaginosis: Fact or fiction? (1999) Curr Infect Dis Rep, 1, pp. 393-397
dc.descriptionAndersch, B., Forssman, L., Lincoln, K., Torstensson, P., Treatment of bacterial vaginosis with an acid cream: A comparison between the effect of lactate-gel and metronidazole (1986) Gynecol Obstet Invest, 21, pp. 19-25
dc.descriptionSimoes, J.A., Discacciati, M.G., Brolazo, E.M., Portugal, P.M., Dini, D.V., Dantas, M.C., Clinical diagnosis of bacterial vaginosis (2006) Int J Gynaecol Obstet, 94, pp. 28-32
dc.descriptionAmsel, R., Totten, P.A., Spiegel, C.A., Chen, K.C.S., Eschenbach, D., Holmes, K.K., Non-specific vaginitis. Diagnostic criteria and microbial and epidemiological associations (1983) Am J Med, 74, pp. 14-22
dc.descriptionNugent, R.P., Krohn, M.A., Hillier, S.L., Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation (1991) J Clin Microbiol, 29, pp. 297-301
dc.descriptionBradshaw, C.S., Morton, A.N., Hocking, J., Garland, S.M., Morris, M.B., Moss, L.M., High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence (2006) J Infect Dis, 193, pp. 1478-1486
dc.descriptionBradshaw, C.S., Tabrizi, S.N., Fairley, C.K., Morton, A.N., Rudland, E., Garland, S.M., The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy (2006) J Infect Dis, 194, pp. 828-836
dc.descriptionGray, R.H., Wabwire-Mangen, F., Kigozi, G., Serwadda, D., Moulton, L.H., Quinn, T.C., Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda (2001) Am J Obstet Gynecol, 185, pp. 1209-1217
dc.descriptionCamargo, R.P., Simões, J.A., Cecatti, J.G., Alves, V.M., Faro, S., Impact of treatment for bacterial vaginosis on prematurity among Brazilian pregnant women: A retrospective cohort study (2005) São Paulo Med J, 123, pp. 108-112
dc.descriptionHay, P., Recurrent bacterial vaginosis (2009) Curr Opin Infect Dis, 22, pp. 82-86
dc.descriptionAlfonsi, G.A., Shlay, J.C., Parker, S., Neher, J.O., What is the best approach for managing recurrent bacterial vaginosis? (2004) J Fam Pract, 53, pp. 650-652
dc.descriptionCDC Sexually Transmitted Disease Treatment Guidelines 2006 (2006) MMWR Morb Mortal Wkly Rep, 55, pp. 50-52. , 2006
dc.description(2006) National Guideline For the Management of Bacterial Vaginosis, , http://www.guide-line.gov, Clinical Effectiveness Group British Association for Sexual Health and HIV, cited 2009 oct. 22. Available from
dc.descriptionSobel, J.D., Ferris, D., Schwebke, J., Nyirjesy, P., Wiesenfeld, H.C., Peipert, J., Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis (2006) Am J Obstet Gynecol, 194, pp. 1283-1289
dc.descriptionHolley, R.L., Richter, H.E., Varner, R.E., Pair, L., Schwebke, J.R., A randomized, double-blind clinical trial of vaginal acidification versus placebo for the treatment of symptomatic bacterial vaginosis (2004) Sex Transm Dis, 31, pp. 236-238
dc.descriptionBoeke, A.J., Dekker, J.H., van Eijk, J.T., Kostense, P.J., Bezemer, P.D., Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: A randomized clinical trial (1993) Genitourin Med, 69, pp. 388-392
dc.descriptionDecena, D.C.D., Co, J.T., Manalastas, R.M., Palaypayon, E.P., Padolina, C.S., Sison, J.M., Metronidazole with Lactacyd vaginal gel in bacterial vaginosis (2006) J Obstet Gynaecol Res, 32, pp. 243-251
dc.descriptionNess, R.B., Kip, K.E., Soper, D.E., Stamm, C.A., Rice, P., Richter, H.E., Variability of bacterial vaginosis over 6 to 12-month intervals (2006) Sex Transm Dis, 33, pp. 381-385
dc.descriptionFerraz do Lago, R., Simões, J.A., Bahamondes, L., Camargo, R.P., Perrotti, M., Monteiro, I., Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections (2003) Contraception, 68, pp. 105-109
dc.descriptionGuaschino, S., Benvenuti, C., SOPHY project: An observational study of vaginal pH, lifestyle and correct intimate hygiene in women of different ages and in different physiopathological conditions (2008) Minerva Ginecol, 60, pp. 353-362. , SOPHY Study Group
dc.languageen
dc.languagept
dc.publisher
dc.relationRevista da Associacao Medica Brasileira
dc.rightsfechado
dc.sourceScopus
dc.titleUse Of A Lactic Acid Plus Lactoserum Intimate Liquid Soap For External Hygiene In The Prevention Of Bacterial Vaginosis Recurrence After Metronidazole Oral Treatment [uso Do ácido Láctico Com Lactoserum Em Sabonete Líquido íntimo Para Higiene Externa Na Prevenção Da Recorrência De Vaginose Bacteriana Após Tratamento Oral Com Metronidazol]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución